ESC 365 - Welcome and introduction - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

ESC Premium Access

Welcome and introduction - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Session: Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)

Topic: Thrombosis and platelets

Speaker: Professor R. Mehran (New York, US)

Sponsored by AstraZeneca

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)

53 presentations

12 followers

3 more presentations in this session

Early initiation of dual anti-platelet therapy following an acute coronary syndrome: a clinical case study.

Speaker: Professor S. James (Uppsala, SE)

Open questions - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor R. Mehran (New York, US) Professor S. James (Uppsala, SE)

Session close - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor R. Mehran (New York, US)

Access the full session

Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)

Speakers: Professor R. Mehran, Professor S. James, Professor R. Mehran, Professor S. James, Professor R. Mehran

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources